• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Pipeline

Pipeline

April 8, 2019
Company Drug/Device Medical Condition Status
Tizona Therapeutics, Inc. TTX-030 cancer Phase I/Ib trial initiated
Amylyx Pharmaceuticals, Inc. AMX0035 Alzheimer’s Disease Phase II trial initiated enrolling 100 subjects
Odonate Therapeutics, Inc. tesetaxel locally advanced or metastatic breast cancer (MBC) Phase II trial initiated
Poxel SA PXL770 non-alcoholic steatohepatitis (NASH) Phase IIa trial initiated enrolling 100 subjects with nonalcoholic fatty liver disease (NAFLD) who likely have NASH at sites in the U.S.
Biohaven Pharmaceutical Holding Company, Ltd. BHV-3500 migraine Phase II/III trial initiated
Hutchison China MediTech Limited surufatinib (HMPL-012 or sulfatinib) with capecitabine advanced biliary tract cancer (BTC) Phase IIb/III trial initiated
PellePharm, Inc. Patidegib Topical Gel, 2% Gorlin Syndrome Phase III trial initiated enrolling 150 subjects
Aldeyra Therapeutics, Inc. topical ocular reproxalap dry eye disease Phase III trial initiated enrolling 400 subjects with moderate-to-severe dry eye disease
ACell, Inc. Gentrix Surgical Matrix gastroenterological or plastic and reconstructive surgery 510(k) clearance granted by the FDA
ACell, Inc. Gentrix Surgical Matrix Thin urological, gastroenterological or plastic and reconstructive surgery 510(k) clearance granted by the FDA
ACell, Inc. Gentrix Surgical Matrix Plus gastroenterological or plastic and reconstructive surgery 510(k) clearance granted by the FDA
AstraZeneca and Merck selumetinib NF1 plexiform neurofibromas Breakthrough Therapy designation granted by the FDA
CSA Medical, Inc. RejuvenAir System moderate to severe chronic obstructive pulmonary disease (COPD) with chronic bronchitis (CB) Breakthrough Device designation granted by the FDA
Fera Pharmaceuticals Avaclyr (acyclovir ophthalmic ointment) herpetic keratitis NDA approval granted by the FDA
Intellirod Spine LOADPRO kyphotic correction surgery De Novo approval granted by the FDA
Immunocore Limited tebentafusp (IMCgp100) metastatic uveal melanoma (mUM) Fast Track approval granted by the FDA
Clarus Therapeutics Jatenzo (testosterone undecanoate) hypogonadism Approval granted by the FDA
EMD Serono Mavenclad (cladribine) relapsing-remitting multiple sclerosis (RRMS) and active secondary progressive disease (SPMS) Approval granted by the FDA

 

Upcoming Events

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing